Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma.
Gracheva MA et al. Leuk Lymphoma. 2015 Apr 24:1-35. [Epub ahead of print].

Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.
Keller S et al. Leuk Res. 2015 Mar 28. pii: S0145-2126(15)00086-7. doi: 10.1016/j.leukres.2015.03.015. [Epub ahead of print].

Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Minarik J et al. PLoS One. 2015 Apr 14;10(4):e0123866. doi: 10.1371/journal.pone.0123866. eCollection 2015.

Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
Shintani T et al. Int J Oral Maxillofac Surg. 2015 Apr 7. pii: S0901-5027(15)00125-3. doi: 10.1016/j.ijom.2015.03.013. [Epub ahead of print].

New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
Kapoulas S et al. Nephrol Ther. 2015 Apr 7. pii: S1769-7255(15)00037-1. doi: 10.1016/j.nephro.2014.12.005. [Epub ahead of print].

Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy.
Lee JY et al. Liver Int. 2015 Mar 31. doi: 10.1111/liv.12838. [Epub ahead of print].

A single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy.
Liu Y et al. Leuk Lymphoma. 2015 Apr 7:1-5. [Epub ahead of print].

The cause of follicular spicules in multiple myeloma.
Hosler GA et al. JAMA Dermatol. 2015 Apr 1;151(4):457-8. doi: 10.1001/jamadermatol.2014.4379.

The cause of follicular spicules in multiple myeloma-reply.
van Boheemen S et al. JAMA Dermatol. 2015 Apr 1;151(4):458. doi: 10.1001/jamadermatol.2014.4385.